Skip to main content
Elsevier

Anti-Aging Pharmacology

  • 1st Edition - December 7, 2022
  • Latest edition
  • Editor: Vitaly Koltover
  • Language: English

**Association of American Publishers (AAP) PROSE Award Finalist in Clinical Medicine, 2024**Anti-Aging Pharmacology provides an overview of current research aimed at the pharmacolo… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

**Association of American Publishers (AAP) PROSE Award Finalist in Clinical Medicine, 2024**

Anti-Aging Pharmacology provides an overview of current research aimed at the pharmacological modulation of aging, including a discussion of the growing number of novel drug classes with promising anti-aging potential. The aging process is the main risk factor for all chronic diseases affecting the elderly. With lifespans extending across the globe, these chronic diseases are placing a larger burden on individuals and health care systems. Therefore, slowing down the aging rate could be more effective in delaying aging-associated chronic disorders than combating them one by one, which is the conventional approach in a current disease-based pharmacological paradigm.

This book contains the work of the world’s leading researchers in the field, including sections on the conceptual and methodological background of anti-aging pharmacology, the basic classes of anti-aging drugs, phytochemicals, outcomes of anti-aging developments and future directions. This book will be of interest to a wide audience, ranging from pharmacologists, medicinal chemists and academic researchers in gerontology, biomedical sciences and those in medical practice.

Key features

  • Includes updated information about current developments in anti-aging pharmacology
  • Offers practical advice on the applicability of certain healthspan-promoting medications
  • Discusses potential challenges related to the translation of anti-aging drugs in clinical practice

Readership

Pharmacologists, medicinal chemists, clinicians, biogerontological researchers, geriatricians

Table of contents

SECTION I. Conceptual and Methodological Backgrounds

1. Can Aging be Cured as a Disease?

2. Geroscience Conceipt

3. Mechanistic Pathways of Aging

4. Biomarkers of Aging Rate

5. Artificial Intelligence-Based Approach in Anti-Aging Pharmacology

6. Big Data Approach

7. OMICs Approaches

SECTION II. Basic Classes of Anti-Aging Drugs

8. Antioxidant Paradox

9. Melatonin

10. Calorie Restriction Mimetics

11. Metformin

12. Rapamycin and rapalogs

13. Nonsteroidal Anti-Inflammatory Drugs

14. Statins

15. Senolytics

16. Epigenetic Drugs

17. Sirtuin Activating Compounds

18. Autophagy Inducers

19. Mitophagy Modulators

20. Telomerase Activators

SECTION III. Phytochemicals

21. Resveratrol

22. Curcumin

23. Quercetin

24. Genistein

25. Epigallocatechin Gallate

26. Berberine

27. Nanodelivery of phytobioactive compounds: a promise in anti-aging medicine

SECTION IV. Outcomes and Concluding Thoughts

28. Ethical perspectives on advances in biogerontology

29. Implications for Public Health Policy

30. The Business of Anti-Aging Science

Product details

  • Edition: 1
  • Latest edition
  • Published: December 7, 2022
  • Language: English

About the editor

VK

Vitaly Koltover

Vitaly K. Koltover D. Sci. (Biology - Biological Physics), Ph. D. (Physics & Mathematics - Chemical Physics) works as the chief researcher in Department of Kinetics of Chemical and Biological Processes, Institute of Problems of Chemical Physics, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia (http://www.icp.ac.ru). Graduated Taras Shevchenko University in Kiev, Ukraine, (former SU), Holds PhD in Physics and Mathematics (Chemical Physics), and SciD in Biology (Biological Physics). As invited scientist, visited Austria (Institute of Pharmacology and Toxicology, Vienna); Germany (Max-Planck Institute for Demographic Research, Rostock and Albert-Ludwig University, Freiburg); India (Indian Institute of Technology, Chennai and Bhabha Atomic Center, Mumbai); Israel (Shamoon College of Engineering, Beer Sheva), USA (National Lawrence Laboratory in Berkeley, University of Pennsylvania in Philadelphia, Northwestern University in Evanston). Presented plenary lectures and oral presentations at the scientific meetings in Russia, Austria, Canada, China, France, Greece, India, Italy, Israel, Japan, Ukraine, and USA. Published more than 300 scientific papers, including books, conference proceedings and papers in the representative journals. Main research interests, at the present time, are reliability (robustness) and aging of biological systems, free radicals and antioxidants, magnetic isotopes and nuclear spin catalysis in living systems.
Affiliations and expertise
Chief Researcher (Principal Investigator), Kinetics of Chemical and Biological Processes, Institute of Problems of Chemical Physics, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russian Federation

View book on ScienceDirect

Read Anti-Aging Pharmacology on ScienceDirect